Stockreport

The Polycythemia Vera Market Landscape Heats Up Amid Rising Competition Among Pharma Companies | DelveInsight [Yahoo! Finance]

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com
PDF already approved products, Incyte/Novartis' JAKAFI and PharmaEssentia/AOP Orphan Pharmaceuticals' BESREMi. In contrast, we also anticipate the launch and potential uptak [Read more]